✨
AI Summary
- Mavacamten shows sustained improvements in obstructive HCM symptoms up to 5 years.
- EXPLORER-LTE study presented at ESC Congress 2026 highlights long-term benefits.
- Treatment with mavacamten offers durable relief for oHCM patients.
Guests on This Episode
AO
Anjali Owens
1 podcast appearance